Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Jasrie Firdaus

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Cell Science|October 13, 2021
A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplexTong San Tan, John E A Common, John S Y Lim, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 10, 2022
Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti-IFN-γ Monoclonal AntibodyCedric Badowski, Tong San Tan, Teimur Aliev, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2024
Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasomePritisha Rozario, Miriam Pinilla, Leana Gorse, et al.
The Journal of Experimental Medicine|August 29, 2023
Diphtheria toxin activates ribotoxic stress and NLRP1 inflammasome-driven pyroptosisKim Samirah Robinson, Gee Ann Toh, Muhammad Jasrie Firdaus, et al.
Molecular Cell|November 26, 2024
The ribotoxic stress response drives acute inflammation, cell death, and epidermal thickening in UV-irradiated skin in vivoAnna Constance Vind, Zhenzhen Wu, Muhammad Jasrie Firdaus, et al.
Experimental Dermatology|July 18, 2025
Ruxolitinib Alleviates Inflammation and Fortifies Skin Barrier Function Through Dampening IL-13Li Fang Koh, Muhammad Jasrie Firdaus, Yohei Natsuaki, et al.
The Journal of Investigative Dermatology|December 13, 2025
IFNγ priming enables NLRP3 inflammasome activation in human keratinocytes in vitroPritisha Rozario, Ying Shiang Lim, Suet Lee Shirley Ding, et al.
Science (New York, N.Y.)|July 20, 2022
ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasomeKim S Robinson, Gee Ann Toh, Pritisha Rozario, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Cell Science|October 13, 2021
A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplexTong San Tan, John E A Common, John S Y Lim, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 10, 2022
Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti-IFN-γ Monoclonal AntibodyCedric Badowski, Tong San Tan, Teimur Aliev, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2024
Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasomePritisha Rozario, Miriam Pinilla, Leana Gorse, et al.
The Journal of Experimental Medicine|August 29, 2023
Diphtheria toxin activates ribotoxic stress and NLRP1 inflammasome-driven pyroptosisKim Samirah Robinson, Gee Ann Toh, Muhammad Jasrie Firdaus, et al.
Molecular Cell|November 26, 2024
The ribotoxic stress response drives acute inflammation, cell death, and epidermal thickening in UV-irradiated skin in vivoAnna Constance Vind, Zhenzhen Wu, Muhammad Jasrie Firdaus, et al.
Experimental Dermatology|July 18, 2025
Ruxolitinib Alleviates Inflammation and Fortifies Skin Barrier Function Through Dampening IL-13Li Fang Koh, Muhammad Jasrie Firdaus, Yohei Natsuaki, et al.
The Journal of Investigative Dermatology|December 13, 2025
IFNγ priming enables NLRP3 inflammasome activation in human keratinocytes in vitroPritisha Rozario, Ying Shiang Lim, Suet Lee Shirley Ding, et al.
Science (New York, N.Y.)|July 20, 2022
ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasomeKim S Robinson, Gee Ann Toh, Pritisha Rozario, et al.
Pageof 1